Bile Duct Cancer - 42 Studies Found
| Completed |
: Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy :
: 2010-12-07 : Dietary Supplement: Oral IMPACT oral supplementation for 5 days (1L/day) before surgery of a formula enr |
| Completed |
: Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas :
: Drug: porfimer sodium |
| Completed |
: Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy :
: 2009-06-11 :
|
| Completed |
: Single Agent Regorafenib in Refractory Advanced Biliary Cancers : Cancer of the Bile Duct : 2014-04-11 : Drug: Regorafenib Four 40 mg regorafenib tables should be taken in the morning with approximately 8 flui |
| Withdrawn |
: Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery :
|
| Completed |
: Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery :
: |
| Completed |
: Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer :
: |
| Terminated |
: Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer :
: Drug: becatecarin Cohorts of 3-6 patients receive escalating doses of rebeccamycin analogue until the ma |
| Enrolling by invitation |
: Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis :
: Device: 'Intra-luminal radiofrequency ablation (Habib EndoHPB) endobiliary radiofrequency ablation devic |
| Completed |
: Quality Of Life in Patients With Malignant Biliary Obstruction :
|